Skip to main content
. 2020 Mar 10;9(3):751. doi: 10.3390/jcm9030751

Table 3.

Comparison between patients with and without pathogenic/likely pathogenic variants.

Characteristic Pathogenic or Likely Pathogenic Variants p Value
Positive (n = 13) Negative (n = 81)
Male sex 11 (84.6) 67 (82.7) 1.000
Age at enrollment, years 15.5 (12.2–19.9) 15.3 (9.3–19.3) 0.360
Age at last follow up, years 18.1 (13.8–22.4) 17.2 (11.9–21.3) 0.324
Renal phenotype 0.293
Bilateral lesions
bRHD with/without Others a 8 (61.5) 36 (44.4)
uAgenesis + cOthers a 1 (7.7) 6 (7.4)
uMCDK + cOthers a 3 (23.1) 6 (7.4)
uRHD + cOthers a 0 11 (13.6)
bVUR 1 (7.7) 13 (16.0)
bObstructive uropathy b 0 4 (4.9)
Unilateral lesions 0 5 (6.2)
Bilateral renal anomalies 10 (76.9) 42 (51.9) 0.091
Kidney function 0.282
Normal 1 (7.7) 5 (6.2)
CKD 4 (30.8) 44 (54.3)
ESRD 8 (61.5) 32 (39.5)
Age at diagnosis of ESRD, years 13.6 (10.4–20.3) 13.9 (8.9–19.7) 0.914
Age at 50% kidney survival c, years 20.8 (10.2–31.4) 20.0 (17.2–22.8) 0.280
Family history of CAKUT d 1 (7.7) 4 (4.9) 0.533
Syndromic CAKUT 11 (84.6) 21 (25.9) <0.001
Premature birth 3 (23.1) 20 (24.7) 1.000
Small for gestational age 3 (23.1) 14 (17.3) 0.698
Oligohydramnios 3 (23.1) 19 (23.5) 1.000

Values are expressed as numbers (%) and median (interquartile range). a Including renal hypodysplasia, multicystic dysplastic kidney, and renal agenesis. b Including posterior urethral valve (n = 3) and bilateral ureteropelvic junction obstruction (n = 1). c The median (95% confidence interval) estimated by Kaplan–Meier survival analysis. d Reporting by the patients and parents. b, bilateral; u, unilateral; c, contralateral; RHD, renal hypodysplasia; VUR, vesicoureteral reflux; MCDK, multicystic dysplastic kidney; CKD, chronic kidney disease; ESRD, end stage renal disease; CAKUT, congenital anomalies of the kidney and urinary tract.